Difference between revisions of "MEDICATION-MIDODRINE"

From NeuroRehab.wiki

(Imported from text file)
(Imported from text file)
Line 4: Line 4:
==Reference(s)==
==Reference(s)==
Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council.
Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council.
American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons.
<br/>American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons.


[[Category:Medication]]
[[Category:Medication]]
[[Category:Advanced Life Support]]
[[Category:Advanced Life Support]]

Revision as of 01:50, 17 December 2022

1. Great drug! Pro-drug: desglymidodrine.

2. Alpha-1 receptor agonist: works on arteries & veins.

3. Peak action in 1-2 hrs post-oral intake, lasting 3-4 hrs. 94% bioavailability.

4. Useful in the ward for patients with sepsis who have been adequately fluid resuscitated. Can also be used in postural hypotension.

5. Dosage: 10 mg Q6h - 20 mg Q6h; just don't send patients home on it! Wean over 3 days.


Reference(s)

Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council.
American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons.